The FDA is proposing a new rule around informing women with dense breasts about the greater risks they have and how this may affect their mammogram results.
Greater awareness of this problem may lead more doctors to use Volpara's systems for breast screening.
https://www.cnbc.com/2019/03/27/fda...men-about-cancer-risks-of-breast-density.html
